TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29560074

Group type: EXPERIMENTAL
Intervention: Static technique
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dynamic technique
Number of subjects: 120
Study: 27052541

Group type: EXPERIMENTAL
Intervention: Food4Me food-frequency questionnaire (FFQ)
Number of subjects: 567
Study: 23660574

Group type: EXPERIMENTAL
Intervention: Wii boxing
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Wii tennis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Wii games (any)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Boxing and cycling
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Boxing and tennis
Number of subjects: 22
Study: 22641306

Group type: EXPERIMENTAL
Intervention: Capnographic monitoring
Number of subjects: 760

Group type: COMPARATOR
Intervention: Standard monitoring
Number of subjects: 760
Study: 20556840

Group type: EXPERIMENTAL
Intervention: Dual specimens (antrum + body)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Single antral specimens
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Newly developed rapid urease tests (HelicotecUT plus test and HelicotecUT test)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Established rapid urease tests (CLO test and ProntoDry test)
Number of subjects: 355
Study: 17432689

Group type: EXPERIMENTAL
Intervention: Routine therapy plus Chinese medicinal compound for EWEPPB
Number of subjects: 68

Group type: COMPARATOR
Intervention: Routine Western therapy alone
Number of subjects: 68
Study: 15803833

Group type: COMPARATOR
Intervention: Cytostatic therapy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cytostatic and antibacterial agents
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cytostatic and antibacterial agents with prebiotic preparations
Number of subjects: 105
Study: 11834137

Group type: EXPERIMENTAL
Intervention: Brachial artery mean 24 h pulse pressure
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined multivariate model
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Brachial artery pulse pressure
Number of subjects: 60
Study: 10632027

Group type: EXPERIMENTAL
Intervention: Histamine injection in area of allodynia (experimental arm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Histamine injection in opposite forearm (control arm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of wheal and flare areas between experimental and control arms
Number of subjects: 0
Study: 7717489

Group type: EXPERIMENTAL
Intervention: Routine management with additional forced-air warming of head, chest, and arms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Routine thermal management (circulating-water mattress set at 42 degrees C, intravenous fluid warming to 37 degrees C and passive insulation)
Number of subjects: 20
Study: 2149553

Group type: EXPERIMENTAL
Intervention: CBM goal and progress monitoring with group follow‐up consultation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: CBM goal and progress monitoring with individual expert follow‐up consultation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: teacher‐developed goal and progress monitoring with group follow‐up consultation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: teacher‐developed goal and progress monitoring with individual expert follow‐up consultation
Number of subjects: 55
Study: 7172410

Group type: EXPERIMENTAL
Intervention: Prednimustine + vincristine
Number of subjects: 67

Group type: COMPARATOR
Intervention: Cytosine arabinoside + thioguanine
Number of subjects: 67
Study: 31777119

Group type: EXPERIMENTAL
Intervention: Colour star rating only
Number of subjects: 1033

Group type: EXPERIMENTAL
Intervention: Coloured HSR variations
Number of subjects: 1033

Group type: EXPERIMENTAL
Intervention: Star-only versions
Number of subjects: 1033

Group type: COMPARATOR
Intervention: B&W full HSR
Number of subjects: 1033
Study: 31252032

Group type: EXPERIMENTAL
Intervention: Dupilumab (200 mg weekly)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 29482038

Group type: EXPERIMENTAL
Intervention: Treat-to-target intervention
Number of subjects: 212

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study: 27470989

Group type: EXPERIMENTAL
Intervention: 30-day ECG monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7-day ECG monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 14-day ECG monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repeat 24-hour ECG
Number of subjects: 0
Study: 24239808

Group type: EXPERIMENTAL
Intervention: Diet-congruent images
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control images (neutral non-food images)
Number of subjects: 67
Study: 22101225

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy delivered via home-based telehealth (HBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prolonged Exposure (PE) therapy delivered in-person
Number of subjects: 0
Study: 20802288

Group type: EXPERIMENTAL
Intervention: Combined weight and pendulum training exercises
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 38
Study: 16823457

Group type: EXPERIMENTAL
Intervention: Alcon AcrySof IOL (MA60AC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: AMO Sensar IOL (AR40e)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both IOL groups
Number of subjects: 45
Study: 16893989

Group type: EXPERIMENTAL
Intervention: TT homozygotes
Number of subjects: 300
Study: 15641542

Group type: EXPERIMENTAL
Intervention: Pleural tent
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group without pleural tent
Number of subjects: 40
Study: 10821361

Group type: EXPERIMENTAL
Intervention: Losartan (titrated to 50 mg once daily)
Number of subjects: 3152

Group type: COMPARATOR
Intervention: Captopril (titrated to 50 mg three times daily)
Number of subjects: 3152
Study: 8773906

Group type: EXPERIMENTAL
Intervention: Acute exacerbations in chronic hepatitis C
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Asymptomatic acute exacerbations
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Histological study of acute exacerbations
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase > or = 300 U/l at entry
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Chronic active hepatitis at entry
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: HCV‐RNA level during acute exacerbations
Number of subjects: 194
Study: 1467375

Group type: EXPERIMENTAL
Intervention: CCK‐4 (10 micrograms)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CCK‐4 (15 micrograms)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CCK‐4 (20 micrograms)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CCK‐4 (25 micrograms)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 6699655

Group type: EXPERIMENTAL
Intervention: Irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 0
Study: 30808080

Group type: EXPERIMENTAL
Intervention: udenafil 50 mg (U50)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: udenafil 100 mg (U100)
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 29321654

Group type: EXPERIMENTAL
Intervention: Information and behavioral nudges (including soft commitments and reminders)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Approaching expecting parents closer to the delivery date and providing multiple reminders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Organizational support
Number of subjects: 0
Study: 26713336

Group type: EXPERIMENTAL
Intervention: Enhanced ICF
Number of subjects: 550

Group type: COMPARATOR
Intervention: Conventional ICF
Number of subjects: 550
Study: 24815831

Group type: EXPERIMENTAL
Intervention: Routine abdominal computed tomography (rCT)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Selective abdominal CT (sCT)
Number of subjects: 203
Study: 22926591

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (titrated up to 150 mg/d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 20601209

Group type: EXPERIMENTAL
Intervention: Acu-TENS
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo-TENS
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham-TENS
Number of subjects: 28
Study: 17660033

Group type: EXPERIMENTAL
Intervention: Rapamycin therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Tacrolimus plus rapamycin
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Long-term rapamycin treatment
Number of subjects: 46
Study: 16098002

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg/day
Number of subjects: 6017

Group type: COMPARATOR
Intervention: Esomeprazole on demand
Number of subjects: 6017

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg/day (acute treatment)
Number of subjects: 6017
Study: 12137725

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 1200 mg per day (3 x 400 mg) orally in addition to local therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Local therapy alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 1200 mg per day
Number of subjects: 80
Study: 10455830

Group type: EXPERIMENTAL
Intervention: Light diet (eating group)
Number of subjects: 94
Study: 7805224

Group type: EXPERIMENTAL
Intervention: 60-microF capacitance biphasic pulse
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 120-microF capacitance biphasic pulse
Number of subjects: 38
Study: 1704545

Group type: EXPERIMENTAL
Intervention: Nonlinear algorithm
Number of subjects: 11

Group type: COMPARATOR
Intervention: Linear algorithm
Number of subjects: 11
Study: 5895

Group type: EXPERIMENTAL
Intervention: Electronic fetal monitoring
Number of subjects: 483

Group type: COMPARATOR
Intervention: Auscultation of fetal heart tones
Number of subjects: 483
Study: 30622047

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy (ACT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 64
Study: 28500682

Group type: EXPERIMENTAL
Intervention: Transfusion
Number of subjects: 204

Group type: COMPARATOR
Intervention: Hydroxyurea use
Number of subjects: 204
Study: 25506771

Group type: EXPERIMENTAL
Intervention: Intervention group (proactive outreach with counseling, NRT, community referrals)
Number of subjects: 707

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: Telephone counseling participation
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: Use of community referral
Number of subjects: 707
Study: 23511989

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy combined with intravesical chemotherapy (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravesical chemotherapy alone (group B)
Number of subjects: 60
Study: 16454146

Group type: EXPERIMENTAL
Intervention: Hatha yoga class
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Walking exercise class
Number of subjects: 135

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 135
Study: 15182984

Group type: EXPERIMENTAL
Intervention: Unilateral anterior cruciate ligament deficiency
Number of subjects: 9
Study: 10740139

Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 8934356

Group type: EXPERIMENTAL
Intervention: Low sodium diet (10-50 mmol/day) for 12 months
Number of subjects: 54

Group type: COMPARATOR
Intervention: Low sodium intake
Number of subjects: 54
Study: 1524754

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer pre‐brush rinse (0.03% triclosan and 0.125% copolymer)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo pre‐brush rinse
Number of subjects: 114
Study: 3905700

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 77

Group type: COMPARATOR
Intervention: Cephalothin
Number of subjects: 77
Study: 31509331

Group type: EXPERIMENTAL
Intervention: Bleselumab + IR-TAC
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Bleselumab + MMF
Number of subjects: 138

Group type: COMPARATOR
Intervention: SoC
Number of subjects: 138
Study: 31151481

Group type: EXPERIMENTAL
Intervention: Continuous cardiac monitoring with ILR implantation plus standard of care
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard of care with annual 24 h or 5‐day Holter monitor
Number of subjects: 164
Study: 28840277

Group type: EXPERIMENTAL
Intervention: 70 kVp with 25 mL contrast medium (CM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 100 kVp with 40 mL contrast medium (CM)
Number of subjects: 50
Study: 26161708

Group type: EXPERIMENTAL
Intervention: 25000 IU/d retinyl palmitate for six months followed by 10000 IU/d retinyl palmitate for another six months
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 24012432

Group type: EXPERIMENTAL
Intervention: Prasugrel (loading dose 60 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: TAP (loading dose aspirin 300 mg, clopidogrel 600 mg, cilostazol 200 mg)
Number of subjects: 70
Study: 21992247

Group type: EXPERIMENTAL
Intervention: Active transcutaneous piezoelectric current (6 µA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (no current)
Number of subjects: 15
Study: 19703071

Group type: COMPARATOR
Intervention: Neoadjuvant radiotherapy
Number of subjects: 473

Group type: COMPARATOR
Intervention: Neoadjuvant radiochemotherapy
Number of subjects: 473

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Surgery alone (control group)
Number of subjects: 473
Study: 17405898

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (cisplatin-based regimens)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhibition of angiogenesis pathways and epidermal growth factor receptor
Number of subjects: 0
Study: 15081328

Group type: EXPERIMENTAL
Intervention: Hypertonic saline dextran (HSD)
Number of subjects: 0
Study: 11457747

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 506

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 506
Study: 9870344

Group type: EXPERIMENTAL
Intervention: Memantine (30 mg p.o.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7986439

Group type: EXPERIMENTAL
Intervention: Clearfil Liner Bond (CLB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gluma 2000
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose (SMP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: In vitro samples
Number of subjects: 40
Study: 2537566

Group type: EXPERIMENTAL
Intervention: Lisinopril (initial dose and maintenance therapy for 12 weeks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lisinopril (readministration after 12 weeks)
Number of subjects: 19
Study: 31023931

Group type: EXPERIMENTAL
Intervention: Genicular nerve radiofrequency ablation (GN-RFA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 70
Study: 27682745

Group type: EXPERIMENTAL
Intervention: Preoperative counseling with the use of a validated, online risk calculator for de novo SUI after POP surgery
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard preoperative counseling
Number of subjects: 33
Study: 25904733

Group type: EXPERIMENTAL
Intervention: Low-calorie cranberry juice (LCCJ)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 56
Study: 23594572

Group type: EXPERIMENTAL
Intervention: Targeted multimedia patient intervention
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Tailored multimedia patient intervention
Number of subjects: 867

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 867
Study: 21772173

Group type: EXPERIMENTAL
Intervention: Macropore
Number of subjects: 331

Group type: COMPARATOR
Intervention: Medpor
Number of subjects: 331
Study: 19493352

Group type: EXPERIMENTAL
Intervention: PCT-guided antibiotic therapy (discontinued if PCT <1 ng/ml or dropped to 25-35% of initial value over three days)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard antibiotic regimen (applied over eight days)
Number of subjects: 110
Study: 16786535

Group type: EXPERIMENTAL
Intervention: Methylthioadenosine (MTA)
Number of subjects: 0
Study: 15571523

Group type: EXPERIMENTAL
Intervention: Melatonin (6-9 mg/day for 14 days)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: COMPARATOR
Intervention: Melatonin and Placebo
Number of subjects: 31
Study: 11091247

Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 51

Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 51
Study: 9264277

Group type: EXPERIMENTAL
Intervention: Supplemental dietary cellulose
Number of subjects: 13

Group type: COMPARATOR
Intervention: No cellulose (control group)
Number of subjects: 13
Study: 8317726

Group type: EXPERIMENTAL
Intervention: Single 0.15 mg/kg bolus of mivacurium (Group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Two 0.075 mg/kg boluses of mivacurium separated by 60 s (Group II)
Number of subjects: 30
Study: 3525714

Group type: EXPERIMENTAL
Intervention: Perforated mallet finger splint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional splint
Number of subjects: 0
Study: 31352797

Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (70% fat, 25% protein, 5% carbohydrate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: American Cancer Society diet (ACS; high-fiber and lower-fat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (KD) adherence
Number of subjects: 0
Study: 29856465

Group type: EXPERIMENTAL
Intervention: Higher intensity itch stimuli during nocebo learning phase
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Induction or reversal of nocebo effects
Number of subjects: 97

Group type: COMPARATOR
Intervention: Lower intensity itch stimuli during nocebo learning phase
Number of subjects: 97
Study: 27690710

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla‐300) with patient support program
Number of subjects: 3270

Group type: COMPARATOR
Intervention: Other basal insulin with available patient support programs
Number of subjects: 3270

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla‐300)
Number of subjects: 3270
Study: 24169027

Group type: EXPERIMENTAL
Intervention: Vortioxetine 5 mg/day (adjustable from 2.5 to 10 mg/day based on response and tolerability)
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Vortioxetine treatment for 52 weeks
Number of subjects: 834
Study: 22809064

Group type: EXPERIMENTAL
Intervention: Diabetes patients with comorbid RA
Number of subjects: 256331

Group type: COMPARATOR
Intervention: Diabetes patients without RA
Number of subjects: 256331
Study: 20966393

Group type: EXPERIMENTAL
Intervention: New method MI (MI-N)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classic method MI (MI-C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham (S-N)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham (S-C)
Number of subjects: 0
Study: 18843828

Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention
Number of subjects: 120
Study: 15741815

Group type: EXPERIMENTAL
Intervention: Topical timolol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 90
Study: 12418566

Group type: EXPERIMENTAL
Intervention: 1% sevoflurane (group S)
Number of subjects: 17

Group type: COMPARATOR
Intervention: 50% nitrous oxide in oxygen (group N)
Number of subjects: 17
Study: 11759128

Group type: EXPERIMENTAL
Intervention: Esmolol 0.2 mg/kg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Esmolol 0.4 mg/kg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 61
Study: 9289466

Group type: EXPERIMENTAL
Intervention: Radiation treatment
Number of subjects: 41
Study: 1830145

Group type: EXPERIMENTAL
Intervention: Ultrasonic nebulizer
Number of subjects: 48

Group type: COMPARATOR
Intervention: Jet nebulizer
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pentamidine mesylate
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pentamidine isethionate
Number of subjects: 48
Study: 6356897

Group type: EXPERIMENTAL
Intervention: Labetalol (100 to 400 mg three times a day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (25 to 50 mg three times a day)
Number of subjects: 20
Study: 30777293

Group type: EXPERIMENTAL
Intervention: Cognitive therapy skill acquisition (CTSA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control procedure focused on being exposed to theories of automatic thinking
Number of subjects: 52
Study: 31279814

Group type: EXPERIMENTAL
Intervention: Letermovir prophylaxis through 14 weeks post-transplant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28614091

Group type: EXPERIMENTAL
Intervention: 40U daxibotulinumtoxinA
Number of subjects: 268

Group type: COMPARATOR
Intervention: 20U onabotulinumtoxinA
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: 60U daxibotulinumtoxinA
Number of subjects: 268

Group type: COMPARATOR
Intervention: 20U daxibotulinumtoxinA
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 26190370

Group type: EXPERIMENTAL
Intervention: Health check and individual lifestyle counselling (intervention group)
Number of subjects: 11629

Group type: COMPARATOR
Intervention: Control group (no health check or lifestyle counselling)
Number of subjects: 11629
Study: 23458606

Group type: EXPERIMENTAL
Intervention: Subtle stereotype threat (ST) condition
Number of subjects: 294

Group type: COMPARATOR
Intervention: Control condition (no ST)
Number of subjects: 294
Study: 21256802

Group type: EXPERIMENTAL
Intervention: Sleep restriction (5, 6, 7, 8, or 9 hours of sleep for four consecutive nights)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Recovery nights (2 nights of recovery sleep)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Polysomnographic monitoring
Number of subjects: 88
Study: 17582406

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0
Study: 16790656

Group type: EXPERIMENTAL
Intervention: Metamizol 1 g
Number of subjects: 80

Group type: COMPARATOR
Intervention: Parecoxib 40 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Paracetamol 1 g
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80